Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
Stintzing, S., Wirapati, P., Lenz, H.-J., Neureiter, D., Fischer von Weikersthal, L., Decker, T., Kiani, A., Kaiser, F., Al-Batran, S., Heintges, T., Lerchenmüller, C., Kahl, C., Seipelt, G., Kullmann, F., Moehler, M., Scheithauer, W., Held, S., Modest, D.P., Jung, A., Kirchner, T., Aderka, D., Tejpar, S., Heinemann, V.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study
Stintzing, S, Miller-Phillips, L, Modest, D.P, Fischer von Weikersthal, L, Decker, T, Kiani, A, Vehling-Kaiser, U, Al-Batran, S.-E, Heintges, T, Kahl, C, Seipelt, G, Kullmann, F, Stauch, M, Scheithauer, W, Held, S, Moehler, M, Jagenburg, A, Kirchner, T, Jung, A, Heinemann, V
Published in European journal of cancer (1990) (01.07.2017)
Published in European journal of cancer (1990) (01.07.2017)
Get full text
Journal Article
Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306)
Holch, J.W., Held, S., Stintzing, S., Fischer von Weikersthal, L., Decker, T., Kiani, A., Kaiser, F., Heintges, T., Kahl, C., Kullmann, F., Scheithauer, W., Moehler, M., von Einem, J.C., Michl, M., Heinemann, V.
Published in Annals of oncology (01.01.2020)
Published in Annals of oncology (01.01.2020)
Get full text
Journal Article
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer–subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306
Stintzing, S., Fischer von Weikersthal, L., Decker, T., Vehling-Kaiser, U., Jäger, E., Heintges, T., Stoll, C., Giessen, C., Modest, D.P., Neumann, J., Jung, A., Kirchner, T., Scheithauer, W., Heinemann, V.
Published in Annals of oncology (01.07.2012)
Published in Annals of oncology (01.07.2012)
Get full text
Journal Article
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)
Michl, M., Stintzing, S., Fischer von Weikersthal, L., Decker, T., Kiani, A., Vehling-Kaiser, U., Al-Batran, S.-E., Heintges, T., Lerchenmueller, C., Kahl, C., Seipelt, G., Kullmann, F., Stauch, M., Scheithauer, W., Hielscher, J., Scholz, M., Mueller, S., Lerch, M.M., Modest, D.P., Kirchner, T., Jung, A., Heinemann, V.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)
Holch, J.W., Ricard, I., Stintzing, S., Fischer von Weikersthal, L., Decker, T., Kiani, A., Vehling-Kaiser, U., Heintges, T., Kahl, C., Kullmann, F., Scheithauer, W., Moehler, M., Jelas, I., Modest, D.P., Westphalen, C.B., von Einem, J.C., Michl, M., Heinemann, V.
Published in European journal of cancer (1990) (01.01.2019)
Published in European journal of cancer (1990) (01.01.2019)
Get full text
Journal Article
Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306)
Miller-Phillips, L., Fischer von Weikersthal, L., Kaiser, F., Al-Batran, S.-E., Heintges, T., Neureiter, D., Kahl, C., Kullmann, F., Moehler, M., Scheithauer, W., Vazart, C., Fontaine, K., Held, S., Modest, D.P., Neumann, J., Jung, A., Kirchner, T., Heinemann, V., Stintzing, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306)
Modest, D.P., Ricard, I., Stintzing, S., Fischer von Weikersthal, L., Decker, T., Kiani, A., Vehling-Kaiser, U., Al-Batran, S.-E., Heintges, T., Kahl, C., Seipelt, G., Kullmann, F., Scheithauer, W., Moehler, M., Westphalen, C.B., Holch, J.W., von Einem, J.C., Held, S., Heinemann, V.
Published in European journal of cancer (1990) (01.10.2017)
Published in European journal of cancer (1990) (01.10.2017)
Get full text
Journal Article
Independent Radiological Evaluation of Objective Response Early Tumor Shrinkage, and Depth of Response in FIRE-3 (AIO KRK-0306)
Heinemann, V., Modest, D., Fischer von Weikersthal, L., Decker, T., Kiani, A., Vehling-Kaiser, U., Al-Batran, S-E., Heintges, T., Lerchenmüller, C., Kahl, C., Seipelt, G., Kullmann, F., Stauch, M., Scheithauer, W., Held, S., Giessen, C., Möhler, M., Jagenburg, A., Stintzing, S.
Published in Annals of oncology (01.06.2014)
Published in Annals of oncology (01.06.2014)
Get full text
Journal Article
PD-027BRAF mutant and RAS mutant patients treated with FOLFIRI plus Bevacizumab or FOLFIRI plus Cetuximab. Role of ETS and molecular markers in FIRE-3 (AIO KRK-0306)
Stintzing, S, Fischer von Weikersthal, L, Decker, T, Kiani, A, Vehling-Kaiser, U, Al-Batran, S-E, Heintges, T, Lerchenmueller, C, Kahl, C, Seipelt, G, Kullmann, F, Stauch, M, Hielscher, J, Lerch, M, Scheithauer, W, Jagenburg, A, Held, S, Modest, D, Jung, A, Kirchner, T, Heinemann, V
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D
Erhardt, A, Blondin, D, Hauck, K, Sagir, A, Kohnle, T, Heintges, T, Häussinger, D
Published in Gut (01.07.2005)
Published in Gut (01.07.2005)
Get full text
Journal Article
ANTI‐INFECTIVE PROPHYLAXIS WITH ACICLOVIR AND COTRIMOXAZOLE SIGNIFICANTLY REDUCES THE RATE OF INFECTIONS AND THERAPY‐ASSOCIATED DEATHS IN ELDERLY PATIENTS WITH DLBCL UNDERGOING R‐CHOP IMMUNOCHEMOTHERAPY
Murawski, N., Amam, J., Altmann, B., Ziepert, M., Haenel, M., Viardot, A., Neubauer, A., Held, G., Truemper, L., Dreyling, M., Kanz, L., Hallek, M., Schmitz, N., Heintges, T., Koelbel, C., Poeschel, V., Pfreundschuh, M.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
Endoscopic therapy for leaks in the gastrointestinal tract, the bile ducts and the pancreas
Wettstein, M, Frieling, T, Lüthen, R, Heintges, T, Niederau, C, Oette, M, Vogt, C, Vom Dahl, S
Published in Zeitschrift fur Gastroenterologie (01.06.2011)
Published in Zeitschrift fur Gastroenterologie (01.06.2011)
Get more information
Journal Article
Therapy outcome in patients with chronic hepatitis C: role of therapy supervision by expert hepatologists
Sagir, A., Heintges, T., Akyazi, Z., Oette, M., Erhardt, A., Häussinger, D.
Published in Journal of viral hepatitis (01.09.2007)
Published in Journal of viral hepatitis (01.09.2007)
Get full text
Journal Article
A multimodal approach in coil embolization of a bile leak following cholecystectomy
Schelhammer, F, Dahl, S Vom, Heintges, T, Fürst, G
Published in Cardiovascular and interventional radiology (01.06.2007)
Published in Cardiovascular and interventional radiology (01.06.2007)
Get full text
Journal Article
Socioepidemiological data on hepatitis delta in a German university clinic--increase in patients from Eastern Europe and the former Soviet Union
Erhardt, A, Knuth, R, Sagir, A, Kirschberg, O, Heintges, T, Häussinger, D
Published in Zeitschrift für Gastroenterologie (01.06.2003)
Published in Zeitschrift für Gastroenterologie (01.06.2003)
Get more information
Journal Article
Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice
Mohr, L, Yoon, S K, Eastman, S J, Chu, Q, Scheule, R K, Scaglioni, P P, Geissler, M, Heintges, T, Blum, H E, Wands, J R
Published in Human gene therapy (01.05.2001)
Published in Human gene therapy (01.05.2001)
Get more information
Journal Article
Combination therapy of active HBsAg vaccination and interferon-α in interferon-α nonresponders with chronic hepatitis B
HEINTGES, Tobias, PETRY, Wolfgang, KALDEWEY, Michaela, ERHARDT, Andreas, WEND, Ulrike C, GERLICH, Wolfram H, NIEDERAU, Claus, HAUSSINGER, Dieter
Published in Digestive diseases and sciences (01.04.2001)
Published in Digestive diseases and sciences (01.04.2001)
Get full text
Journal Article
Capreomycin in the treatment of atypical mycobacterial disease in HIV-positive patients
GÖBELS, K, HEMKER, J, OETTE, M, WETTSTEIN, M, HEINTGES, T, TEICHMANN, D, MACKENZIE, C. R, HÄUSSINGER, D
Published in European journal of clinical microbiology & infectious diseases (01.07.2002)
Published in European journal of clinical microbiology & infectious diseases (01.07.2002)
Get full text
Journal Article
328 Comparison of 48 or 72 weeks of treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C infected with HCV genotype 1
Berg, Thomas, Von Wagner, M., Hinrichsen, H., Heintges, T., Buggisch, P., Goeser, T., Rasenack, J., Pape, G.R., Schmidt, W.E., Kallinowski, B., Klinker, H., Spengler, U., Klapperich, B., Popescu, M., Zeuzem, S.
Published in Hepatology (Baltimore, Md.) (2003)
Published in Hepatology (Baltimore, Md.) (2003)
Get full text
Journal Article